Doing Well. Doing Good. That’s how we see our healthcare practice. Doing well is measured by our community’s consistency in taking raw but novel concepts and creating important, successful businesses. Doing good relates to the mission and aspirations of our companies. It means improving the lives and wellbeing of the people they serve. We want to create and invest in companies that provide meaningful and lasting benefit to patients around the world.
Our healthcare community includes some of the most important entrepreneurial investigators, physicians, and executives in science and healthcare today, and this network only gets stronger with time and success.
Together, we bring expertise in all areas of drug, medical device, and healthcare service development. From complex clinical trial design to medical device and healthcare services reimbursement; our community and healthcare team have worked successfully across all stages and areas of company development.
We’re not afraid to go early. This means not just seeding companies, but often working with academics and entrepreneurs at the ideation stage, months or years before a company is formed. We are committed, long-term partners, supporting these companies through their growth. We also invest at later rounds and provide growth equity to revenue generating, high-growth businesses.
|Biotechnology & Pharmaceuticals||Medical Devices||Healthcare Services||Healthcare IT|
AgBiome is a product-oriented biotechnology company focused on delivering the best early-stage research and discovery to the agriculture industry.
Editas Medicine is a transformative genome editing company focused on generating a novel class of therapeutics for a broad range of genetic diseases.
Alector is dedicated to the discovery and development of novel therapeutics for Alzheimer’s disease, other forms of dementia, and mechanistically related neurodegenerative disorders.
NextCODE Health is a sequence-based clinical diagnostics company delivering a powerful solution to genome interpretation and big data challenges.
XTuit Pharmaceuticals was founded in 2011 by Harvard Professor Rakesh Jain, MIT Professor Bob Langer and Polaris partner Alan Crane. The company is pursuing novel approaches to improving cancer therapy by targeting the tumor microenvironment.
Scholar Rock is a biotechnology company developing novel therapeutics for the treatment of intractable diseases.
Quantum Designs is leading a revolution in nutrition with new delivery systems that aim to eliminate plastic packaging and improve healthy convenience in a wide range of nutritional products.
Life Line Screening’s mission is to make people aware of unrecognized health problems and encourage them to seek follow-up care with their personal physician. The company is the leading provider of community-based preventive health screenings in the Unite
U.S. HealthVest provides specialized, high quality psychiatric care, including substance abuse treatment, through a broad range of inpatient and outpatient programs.